Cardlytics Inc
Cardlytics Inc provides data-driven marketing and financial technology solutions to banks and retailers, enabling targeted advertising and transaction-based rewards programs.
Business. Cardlytics Inc (CDLX.O) is a software company operating within the Technology sector, specifically in the Software & IT Services industry. The firm utilizes a subscription-based revenue model, with key performance indicators including annual recurring revenue and net revenue retention. Specific details regarding operating segments and geographic mix are not available. The company is listed under the ticker CDLX.O.
Analyst recommendations
5 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Cardlytics Inc (CDLX.O) is a software company operating within the Technology sector, specifically in the Software & IT Services industry. The firm utilizes a subscription-based revenue model, with key performance indicators including annual recurring revenue and net revenue retention. Specific details regarding operating segments and geographic mix are not available. The company is listed under the ticker CDLX.O.
Cardlytics operates with a negative equity position of -$6.5 million and a debt-to-equity ratio of -32.1, indicating a highly leveraged capital structure. The company holds $48.7 million in cash and equivalents but faces $208.9 million in long-term debt, resulting in a net cash position of -$160.2 million. Despite a current ratio of 1.75, the negative equity and high leverage suggest liquidity risk remains a concern.
Profitability metrics reveal significant challenges. The company reported a net loss of $103.5 million and an operating loss of $101.8 million in the latest period. Return on equity (ROE) of 15.9% is unusually high given the negative equity, while return on assets (ROA) is -0.36%, indicating poor asset utilization. Gross profit of $130.3 million represents 55.9% of revenue, but operating margin is -43.6%, far below typical software industry benchmarks.
Geographic and segment exposure is not disclosed in the available data, but the company's business model is concentrated in the U.S. financial services and retail sectors. This concentration increases vulnerability to macroeconomic shifts in consumer spending and banking regulations.
Growth trajectory is mixed. Revenue of $233.3 million reflects a 12.3% year-over-year increase, but operating cash flow of $9.3 million contrasts with a $94.0 million free cash flow deficit. The company's market cap of $35.6 million is significantly below revenue, suggesting market skepticism about future cash flow potential.
Risk factors include high leverage, negative equity, and a free cash flow deficit. The risk assessment flags net cash as negative after subtracting total debt, and liquidity is rated as medium. No dilution risk is currently flagged, but the company's capital structure leaves room for potential equity issuance.
Recent events include a 12.3% revenue growth and a $9.3 million operating cash flow, but no material filings or transcripts are disclosed in the available data. Analysts have assigned a mean price target of $1.04 with a "Hold" consensus, reflecting cautious expectations.
- Cardlytics operates with a negative equity position and high leverage, raising concerns about financial stability.
- Despite a 12.3% revenue growth, the company's operating and net losses persist, indicating unprofitability.
- The business model is concentrated in U.S. financial services and retail, increasing exposure to macroeconomic and regulatory risks.
- Analysts have assigned a "Hold" consensus with a mean price target of $1.04, suggesting limited upside potential.
- Liquidity risk remains elevated due to a $160.2 million net cash deficit and a free cash flow deficit of $94.0 million.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,72 |
| Revenue | —no estimate | —no estimate | 161,3M USD |
| Operating income | —no estimate | —no estimate | -31,1M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director · Restricted Stock Unit → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director · Restricted Stock Units → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Unit → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director · Restricted Stock Units → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director · Restricted Stock Unit → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director · Restricted Stock Units → Common StockAcquired 11 000grant · 2026-05-20
- Director · Restricted Stock Units → Common StockDisposed 11 000exercise · 2026-05-20
- Director, Chief Executive Officer · Restricted Stock Units → Common StockDisposed 14 350exercise · 2026-04-01
- Director, Chief Executive Officer · Restricted Stock Units → Common StockDisposed 500 000exercise · 2026-04-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 582exercise · 2026-04-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 1 578exercise · 2026-04-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 10 630exercise · 2026-04-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 12 500exercise · 2026-04-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 60 000exercise · 2026-04-01
- Director, Chief Executive Officer · Restricted Stock Units → Common StockAcquired 1 500 000grant · 2026-02-27
- Chief Legal & Privacy Officer · Restricted Stock Unit → Common StockAcquired 220 000grant · 2026-02-18
- Director, Chief Executive Officer · Restricted Stock Units → Common StockDisposed 125 000exercise · 2026-02-16
- Chief Financial Officer · Restricted Stock Units → Common StockAcquired 1 000 000grant · 2026-01-12
- Chief Legal & Privacy Officer · Restricted Stock Unit → Common StockDisposed 581exercise · 2026-01-01
- Chief Legal & Privacy Officer · Restricted Stock Units → Common StockDisposed 1 578exercise · 2026-01-01
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Cardlytics Inc Market data — financials · 2026-05-27
- Cardlytics Inc Market data — analyst estimates · 2026-05-27
- Cardlytics Inc Market data — ESG · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2024-06-300,00 %$26M
- Institutional Investor · as of 2022-09-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2024-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockOther 11 000 · 2026-05-20
- Director · Common StockOther 11 000 · 2026-05-20
- Director · Common StockOther 11 000 · 2026-05-20
- Director · Common StockOther 11 000 · 2026-05-20
- Director · Common StockOther 11 000 · 2026-05-20
- Director · Common StockOther 11 000 · 2026-05-20
- Chief Financial Officer · Common StockBought 50 000 @ $0,63$32K · 2026-05-18
- Chief Financial Officer · Common StockBought 150 000 @ $0,65$97K · 2026-05-15
- Director, Chief Executive Officer · Common StockSold 69 833 @ $1,19$83K · 2026-04-06
- Director, Chief Executive Officer · Common StockSold 54 225 @ $1,04$57K · 2026-04-02
- Director, Chief Executive Officer · Common StockOther 500 000 · 2026-04-01
- Director, Chief Executive Officer · Common StockSold 62 549 @ $0,99$62K · 2026-04-01
- Chief Legal & Privacy Officer · Common StockOther 1 578 · 2026-04-01
- Chief Legal & Privacy Officer · Common StockOther 10 630 · 2026-04-01
- Chief Legal & Privacy Officer · Common StockOther 12 500 · 2026-04-01
- Chief Legal & Privacy Officer · Common StockOther 60 000 · 2026-04-01
- Chief Legal & Privacy Officer · Common StockSold 40 296 @ $0,99$40K · 2026-04-01
- Director, Chief Executive Officer · Common StockOther 14 350 · 2026-04-01
- Chief Legal & Privacy Officer · Common StockOther 582 · 2026-04-01
- Director, Chief Executive Officer · Common StockSold 45 159 @ $0,93$42K · 2026-02-18
- Director, Chief Executive Officer · Common StockSold 52 049 @ $0,90$47K · 2026-02-17
- Director, Chief Executive Officer · Common StockOther 125 000 · 2026-02-16
- Chief Legal & Privacy Officer · Common StockSold 6 253 @ $1,17$7K · 2026-01-05
- Chief Financial Officer · Common StockSold 8 607 @ $1,17$10K · 2026-01-05
- Director, Chief Executive Officer · Common StockSold 5 807 @ $1,17$7K · 2026-01-05
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on assets (FY 2025-12-31): -36.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 50.1%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -9.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -27.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -109.3%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -16.2%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -19.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 47.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 205.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 45.0%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -2.2%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 50.1%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -25.7%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -69.3%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -44.89xDerived (calculated)
- Current ratio (FY 2025-12-31): 1.75xDerived (calculated)
- Return on equity (FY 2025-12-31): 1,598.0%Derived (calculated)
- Net margin (FY 2025-12-31): -44.6%Derived (calculated)
- Current assets (annual): USD 137.28MSEC XBRL filing
- Total assets (annual): USD 285.64MSEC XBRL filing
- R&D expense (annual): USD 39.77MSEC XBRL filing
- Net income (annual): USD -104MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
- Revenue (annual): USD 233.27MSEC XBRL filing